Rapid HIV, HCV, and syphilis screening at a rural street-medicine clinic

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates a rapid, point-of-care fingerstick test for HIV, hepatitis C, and syphilis during mobile clinic visits in rural West Virginia. Participants can choose rapid testing, traditional blood draw with HBV screening, or decline testing, and will complete a brief survey about their screening experience. The goal is to see whether rapid testing improves screening uptake, timely linkage to care, and overall patient satisfaction in a high-risk population. Results are available within 10–20 minutes, potentially reducing barriers related to mistrust, logistics, and delays. The setting is WVU Medicine Street Medicine in Harpers Ferry, WV, led by WVU with street-medicine support.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients of the WVU Medicine Street Medicine team

Exclusion Criteria:

* Patients under the age of 18

Where it's running

• WVU Department of Family Medicine - Eastern Division
  Harpers Ferry, West Virginia, United States Recruiting

Study contacts

• Principal investigator: Dana Bechtold, DO — West Virginia University
• Study coordinator: Dana Bechtold, DO
• Email: dana.bechtold@hsc.wvu.edu
• Phone: 304-535-6343

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Hepatitis C care in housing: pharmacist, clinician, and navigator team helps residents

  We're testing a team-based approach to help adults living in supportive housing get faster access to hepatitis C medicines and care.

  Recruiting University of Washington · Seattle, Washington · NCT07667101

• Doxycycline to prevent bacterial STIs in sexual and gender minorities in Rio de Janeiro.

  This research will try taking doxycycline after sex to see if it lowers the chance of syphilis, gonorrhea, and chlamydia for men who have sex with men, transgender women, and travestis in Rio de Janeiro who are living with HIV or using PrEP.

  Recruiting Oswaldo Cruz Foundation · Rio de Janeiro, Rio de Janeiro · NCT07500415

• Where syphilis bacteria live and whether they can spread from symptom-free sites in women and men who have sex with women

  This study will test whether syphilis bacteria found on symptom-free body sites are alive and how long they can be detected in women and men who have sex with women only.

  Recruiting at 3 sites Monash University · Melbourne, Victoria and 8 other locations · NCT07300254

• UV-treated, antiviral-protected lungs from Hepatitis B–positive donors for transplant

  This will try using lungs from hepatitis B–positive donors that are treated with UV light during ex vivo lung perfusion plus post-transplant antiviral medicines to see if they can be safely transplanted into HBV-negative lung transplant candidates.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07189377

• MagIA H3S multiplex rapid blood test for HIV, hepatitis B and C, and syphilis

  This project will test a single blood-based point-of-care test that checks for HIV, hepatitis B and C, and syphilis using serum or plasma samples from people at sites in Ivory Coast and Kenya.

  Recruiting at 2 sites MagIA Diagnostics · Abidjan and 1 other locations · NCT07170748

• Long-term outcomes of pegylated interferon alfa-2b in families with clustered hepatitis B and high risk of cirrhosis or liver cancer

  This study will try pegylated interferon alfa-2b to see if it improves long-term outcomes for people with chronic hepatitis B from families where cirrhosis or liver cancer affects two generations.

  Recruiting First Affiliated Hospital Xi'an Jiaotong University · Xi'an, Shaanxi and 1 other locations · NCT07079150

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.